Jagat Narula, MD, PhD, Designated Master of the American College of Cardiology in Recognition of Outstanding Service
Dr. Narula is the Director of the Cardiovascular Imaging Program at Mount Sinai Heart.
Jagat Narula, MD, PhD, the Philip J. and Harriet L. Goodhart Chair in Cardiology in the Department of Medicine at The Icahn School of Medicine at Mount Sinai was designated a Master of the American College of Cardiology (MACC) during the College's 62nd annual Scientific Session in San Francisco. The MACC is bestowed upon Fellows who have "consistently contributed to the goals and programs of the College, and who have provided leadership in important College activities." Dr. Narula, who also was the recipient of a Gifted Educator Award from the ACC in 2012, is a renowned translational researcher and educator in cardiovascular imaging, and known for his contributions toward preventing and understanding heart attacks and heart failure. For his substantial contributions to the cardiovascular research, he was also designated as one of the five "Innovators of CV Medicine" in the last year's ACC Annual Meeting in Chicago.
"As an educator and as a colleague, Dr. Narula continues to embody the commitment to translational research and education in cardiology, not only as a physician and professor at Mount Sinai, but also as a distinguished member of the American College of Cardiology," said Valentin Fuste, MD, PhD, Physician-in-Chief of The Mount Sinai Medical Center, and Director of Mount Sinai Heart, The Zena and Michael A. Wiener Cardiovascular Institute, and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. "There is no greater legacy for a physician than the knowledge passed down to the next generation of doctors and scientists, and in Dr. Narula we have a great educator who has gone above and beyond in helping to better his fellow physicians. I congratulate him for this well-deserved honor." Dr. Fuster himself was declared as one of the five "Legends of CV medicine" during the 2012 ACC Annual Meeting in Chicago.
Dr. Narula is the Director of the Cardiovascular Imaging Program at Mount Sinai Heart, and the Associate Dean of Global Health and Professor of Medicine at The Icahn School of Medicine at Mount Sinai. During his 24 years of service, he has mentored numerous clinical and research fellows, many of whom working in his research laboratory have been recognized with young investigator awards themselves from prestigious professional organizations.
"For more than 60 years, the ACC has dedicated itself to furthering the field of cardiovascular medicine through education – a charge that all of its members, myself included, take as our utmost responsibility," said Dr. Narula. "And it is a singular honor to be recognized by this distinguished organization. I look forward to continuing my work with the College and its member physician-scientists, many of whom I have come to call my peers, my colleagues, and my friends."
Pioneering work from Dr. Narula has included the description of the phenomenon of heart muscle cell suicide, and the detection of atherosclerotic plaques that are likely to cause acute heart attacks. His research has been funded in part by grants from the National Institutes of Health (NIH); with more than 750 original research publications or presentations and more than 25 books or journal supplements edited, Dr. Narula has received numerous awards from professional organizations. As a translational researcher, he has been published in both basic science and clinical journals, including Nature Medicine, Science, PNAS, the New England Journal of Medicine, and the Lancet.
Dr. Narula serves on various committees of the American College of Cardiology and the American Heart Association. He is the Editor-in-Chief of the Journal of American College of Cardiology-CV Imaging, as also the journal, Global Heart. Dr. Narula was also a former founding Editor-in-Chief of the Heart Failure Clinics of North America. He is actively involved in population-based heart attack prevention programs, including the multinational Heart Attack Prevention Program for You (HAPPY).
After completing his cardiology fellowship training and PhD in Cardiovascular Immunology from the All India Institute of Medical Sciences in Delhi, India, Dr. Narula began work at Massachusetts General Hospital and Harvard Medical School in 1989. There, he completed cardiology, heart failure and transplantation, and nuclear cardiology fellowships, and joined the cardiology faculty. In 1997, he moved to the Hahnemann University School of Medicine, Philadelphia. He was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the Department of Internal Medicine, and Director of Heart Failure and Transplantation Center at Hahnemann, when he relocated to the University of California (Irvine) School of Medicine in 2003. At the UC Irvine, he served as the Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine's Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute, and Medical Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology, before joining Mount Sinai in April, 2011.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine is one of the leading medical schools in the United States, and is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.
# # #